Interpretation of urinary concentrations of pseudoephedrine and its metabolite cathine in relation to doping control

Drug Testing and Analysis

Volumn 1, Issue 5, 2009, Pages 209-213

  Deventer, K ^a   Van Eenoo, P ^a   Baele, G ^b   Pozo, O J ^a   Van Thuyne, W ^a   Delbeke, F T ^a  

^a GHENT UNIVERSITY   (Belgium)

^b Department of Plant Systems Biology ^*  (Belgium)

Author keywords

Amphetamine; Cathine; Doping; Ephedrine; Pseudoephedrine; Sports; Urine

Indexed keywords

BODY FLUIDS; DRUG PRODUCTS;

AMPHETAMINE; CATHINE; DOPING CONTROL; EPHEDRINE; PSEUDOEPHEDRINE; STATISTICAL COMPARISONS; URINE; URINE SAMPLE; WORLD ANTI-DOPING AGENCY;

SPORTS;

NORPSEUDOEPHEDRINE; PSEUDOEPHEDRINE;

ADULT; ARTICLE; CONTROLLED STUDY; CYCLING; DOPING; DRUG ABUSE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MAXIMUM ALLOWABLE CONCENTRATION; NORMAL HUMAN; PRIORITY JOURNAL; URINALYSIS; URINARY EXCRETION; VOLUNTEER;

EID: 74049102818     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.31     Document Type: Article

References (21)

1. W. Van Thuyne, P. Van Eenoo, F. T. Delbeke, Nutr. Res. Rev. 2006, 19, 147.
2. D. G. Bell, T. M. McLellan, C. M. Sabiston, Med. Sci. Sports Exerc. 2002, 34, 344.
3. R. Bouchard, A. R. Weber, J. D. Geiger, Clin. J. Sport Med. 2002, 12, 209.
4. I. Jacobs, H. Pasternak, D. G. Bell, Med. Sci. Sports Exerc. 2003, 35, 987.
5. N. D. Gill, A. Shield, A. J. Blazevich, S. Zhou, R. P. Weatherby, Br. J. Clin. Pharmacol. 2000, 50, 205.
6. N. Chester, T. Reilly, D. R. Mottram, Int. J. Sports Med. 2003, 24, 3.
7. K. Hodges, S. Hancock, K. Currell, B.Hamilton, A. E. Jeukendrup, Med. Sci. Sports Exerc. 2006, 38, 329.
8. K. S. Chu, T. J.Doherty, G. Parise, J. S.Milheiro, M. A. Tarnopolsky, Clin. J. Sport Med. 2002, 12, 387.
9. H. Gillies, W. E. Derman, T. D. Noakes, P. Smith, A. Evans, G. Gabriels, J. Appl. Physiol. 1996, 81, 2611.
10. G. Jones, in Essays in Biochemistry, Volume 44: Drugs and Ergogenic Aids to Improve Sport Performance, (Eds: C. E. Cooper, R. Beneke), Portland Press: London, 2008, pp. 109-123.
11. WADA. The World Anti-Doping Agency, The 2009 Prohibited List, Montreal, 2009., http://www.wada-ama.org/rtecontent/document/2009 Prohibited List ENG Final 20 Sept 08.pdf (accessed 4th June 2009).
12. IOC,The International Olympic Committee, List of Prohibited Classes of Substances and Prohibited Methods, Lausanne, 2001.
13. K. Deventer, O. J. Pozo, P. Van Eenoo, F. T. Delbeke, J. Chromatogr. B 2009, 877, 369.
14. P. Van Eenoo, F. T. Delbeke, K. Roels, P. De Backer, J. Chromatogr. B 2001, 760, 255.
15. N. Chester, D. R. Mottram, T. Reilly, M. Powell, Br. J. Clin. Pharmacol. 2004, 57, 62.
16. D. C. Brater, S. Kaojarern, L. Z. Benet, E. T. Lin, T. Lockwood, R. C. Morris, E. J. Mcsherry,K. L. Melmon, Clin.Pharmacol.Ther.1980, 28, 690.
17. G. R. Wilkinso, A. H. Beckett, J. Pharmacol. Exp. Ther. 1968, 162, 139.
18. Y. L. Tseng, M. H. Shieh, F. H. Kuo, Forensic. Sci. Int. 2006, 157, 149.
19. L. Y. Lo, G. Land, A. Bye, J. Chromatogr. 1981, 222, 297.
20. C. M. Lai, R. G. Stoll, Z. M. Look, A. Yacobi, J. Pharm. Sci. 1979, 68, 1243.
21. W. Van Thuyne, F. T. Delbeke, Int. J. Sports Med. 2006, 27, 745.